Forging a position as an innovative player in
infectious disease vaccines and therapies

Home
About
Our Technology
Business Development
- Partner Network
- Licensing Strategy and Available Licenses
Investor Relations
Contact Us
- Corporate directory

BioDiem » Newsletters

Newsletters

Opal Biosciences Investor Briefing, Sydney 13 July 2015

Opal Biosciences Investor Briefing, Melbourne 14 July 2015

Latest News

BioDiem Releases Half Year Results

March 20, 2019

BioDiem Half Year Results – 31 December 2018

Read More
BioDiem Half-year Financial Report – 31 December 2018

March 20, 2019

Half-year Financial Report – 31 December 2018

Read More

Join our email list!

Join our email distribution list to be updated with announcements.

© Copyright 2014 BioDiem

Privacy Policy
Terms and conditions